Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):547-8. doi: 10.1097/00126334-200204150-00019.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Chemoprevention
  • Drug Therapy, Combination
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Lamivudine / adverse effects*
  • Lamivudine / therapeutic use
  • Male
  • Nelfinavir / adverse effects*
  • Nelfinavir / therapeutic use
  • Occupational Exposure
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Stavudine / adverse effects*
  • Stavudine / therapeutic use
  • Surveys and Questionnaires

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Stavudine
  • Nelfinavir